Ensign Peak Advisors’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.81M Sell
57,381
-18,188
-24% -$1.54M 0.01% 624
2026
Q1
$7.51M Sell
75,569
-5,034
-6% -$657K 0.01% 460
2025
Q4
$9.81M Buy
80,603
+5,972
+8% +$749K 0.02% 412
2025
Q3
$8.37M Sell
74,631
-23,150
-24% -$2.71M 0.01% 492
2025
Q2
$13.1M Sell
97,781
-9,837
-9% -$1.08M 0.02% 407
2025
Q1
$7.24M Sell
107,618
-7,168
-6% -$493K 0.01% 544
2024
Q4
$7.16M Sell
114,786
-34,313
-23% -$3.19M 0.01% 553
2024
Q3
$23.4M Sell
149,099
-5
-0% -$770 0.04% 293
2024
Q2
$22.5M Sell
149,104
-22,405
-13% -$2.69M 0.04% 299
2024
Q1
$12.7M Sell
171,509
-818
-0.5% -$67.4K 0.02% 405
2023
Q4
$13.6M Sell
172,327
-11,615
-6% -$701K 0.03% 365
2023
Q3
$10.1M Buy
183,942
+94,346
+105% +$6.79M 0.02% 392
2023
Q2
$7.52M Buy
89,596
+6,464
+8% +$495K 0.02% 489
2023
Q1
$6.3M Buy
83,132
+39,332
+90% +$2.72M 0.01% 505
2022
Q4
$2.7M Buy
43,800
+3,600
+9% +$191K 0.01% 720
2022
Q3
$1.68M Buy
40,200
+35,120
+691% +$1.53M ﹤0.01% 850
2022
Q2
$160K Hold
5,080
﹤0.01% 1861
2022
Q1
$137K Hold
5,080
﹤0.01% 1968
2021
Q4
$97K Buy
+5,080
New +$127K ﹤0.01% 2065

Other funds holding TMDX

Ensign Peak Advisors's TMDX Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Transmedics (TMDX) stake by 24% in Q2 2026, selling an estimated $1.54M and leaving 57,381 shares worth $3.81M. The position accounts for 0.01% of the portfolio, ranked #624.

Ensign Peak Advisors first reported a position in TMDX in Q4 2021 and has held it in 19 quarters since. The position peaked at $23.4M in Q3 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Ensign Peak Advisors held 57,381 shares of Transmedics worth $3.81M as of Q2 2026.
  • Ensign Peak Advisors sold 18,188 Transmedics shares in Q2 2026, an estimated $1.54M.
  • Transmedics made up 0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #624 holding.
  • Ensign Peak Advisors first reported a position in Transmedics in Q4 2021 and has held it in 19 quarters since.
  • Ensign Peak Advisors's Transmedics position peaked at $23.4M in Q3 2024.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.